U.S. Markets closed

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Shin Poong Pharm.Co.,Ltd. (019170.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
6,330.00-330.00 (-4.95%)
At close: 3:30PM KST

Shin Poong Pharm.Co.,Ltd.

748-31 Yeoksam-dong
South Korea
82 2 2189 3500

Full Time Employees


Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. It offers cardiovascular, anti-cancer, psychoneurotic, antirheumatic, antihistamine, and benign prostatic hyperplasia drugs, as well as antibiotics, antiulcerants, anti-diabetics, antifungal and antiviral agents, and trichogens. The company also provides NSAIDs, cardiovascular, anti-ulcer, respiratory, anti-diabetics, antibiotics, propulsive, anti-cancer, anti-arthritis, anti-spasmodic, and anti-helminthic active pharmaceutical ingredients (APIs). In addition, the company offers chemotherapeutics; hormones; contraceptive agents; vitamins and minerals; nutrition and dermatological products; eye, ear, and mouth preparations; and medical device anti-adhesion barriers, as well as neuro-muscular system, hematopoietic system, metabolism, alimentary system, respiratory system, genito-urinary system, and allergy and immune system APIs. It also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is based in Seoul, South Korea.

Corporate Governance

Shin Poong Pharm.Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.